Renewal of Provisional Consent to the Distribution of Medicines

Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicines set out in the Schedule hereto:

Schedule

Product:
Active Ingredient:

Dosage Form:
New Zealand Sponsor:
Manufacturer:

Noradrenaline Tartrate
Noradrenaline acid tartrate monohydrate 0.12g/L
equivalent to noradrenaline base 0.06 g/L
Solution for infusion
Biomed Limited
Biomed Limited, Auckland, New Zealand

Note: This renewed consent is valid for two years from 2 December 2017.

Product:
Active Ingredient:

Dosage Form:
New Zealand Sponsor:
Manufacturer:

Noradrenaline Tartrate
Noradrenaline acid tartrate monohydrate 0.199g/L
equivalent to noradrenaline base 0.1 g/L
Solution for infusion
Biomed Limited
Biomed Limited, Auckland, New Zealand

Note: This renewed consent is valid for two years from 2 December 2017.

Product:
Active Ingredient:

Dosage Form:
New Zealand Sponsor:
Manufacturer:

Noradrenaline Tartrate
Noradrenaline acid tartrate monohydrate 0.239g/L
equivalent to noradrenaline base 0.12 g/L
Solution for infusion
Biomed Limited
Biomed Limited, Auckland, New Zealand

Note: This renewed consent is valid for two years from 2 December 2017.

Product:
Active Ingredient:

Dosage Form:
New Zealand Sponsor:
Manufacturer:

Noradrenaline Tartrate
Noradrenaline acid tartrate monohydrate 0.319g/L
equivalent to noradrenaline base 0.16 g/L
Solution for infusion
Biomed Limited
Biomed Limited, Auckland, New Zealand

Note: This renewed consent is valid for two years from 2 December 2017.

Dated this 2nd day of November 2017.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Renewal of Provisional Consent to the Distribution of Medicines

Tags

Notice Number

Schedule